Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FTC orders Rite Aid to divest pharmacies

Executive Summary

Rite Aid must sell 23 of the Brooks and Eckerd pharmacies it plans to acquire from the Jean Coutu Group, the Federal Trade Commission announces June 4. Rite Aid announced in August 2006 an agreement to purchase 338 Brooks and 1,516 Eckerd stores, making Rite Aid the third largest chain drug store (1"The Pink Sheet" Aug. 28, 2006, p. 20). "The consent order with the Commission requires the companies to sell pharmacies in all of the markets where competition would be adversely affected by the proposed transaction," Jeffrey Schmidt, director of FTC's Bureau of Competition says in a written release. Commission-approved sales include those to Kinney Drugs, Medicine Shoppe, Walgreen, Big Y, and Weis Markets...

You may also be interested in...

Rite Aid Purchase Will Absorb Brooks/Eckerd Pharmacy “Best Practices”

Rite Aid's purchase of Jean Coutu Group's Eckerd and Brooks chain drug stores will improve pharmacy operations by enabling the firm to adopt the other pharmacies' "best practices," Rite Aid CEO Mary Sammons said

Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift

Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.

Liquid Biopsy Company Delfi Diagnostics Raised $100M For New Class of Early Cancer Detection Test

Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials. 




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts